MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2012

Jun 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNTA PHARMACEUTICALS CORP (SNTA)
CIK: 0001157601
Period of Report: 2012-06-04

Reporting Person: Rieder Wendy E (VP, IP and Legal, Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-04	Common Stock	M	7170	$2.49	Acquired	26993	Direct
2012-06-04	Common Stock	S	7170	$5.50	Disposed	19823	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-04	Employee Stock Option (Right to Buy)	$2.49	M	7170	Disposed	2019-04-13	Common Stock (7170)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2011.

F2: The option vested as to 50% of the shares on January 13, 2010 and as to the remaining 50% of the shares on October 13, 2010.